by Combat Cancer | Jan 31, 2025 | News
Pancreatitis, whether acute or chronic, can increase the risk of pancreatic cancer over time. Chronic inflammation can promote cell proliferation, cause DNA damage, and induce angiogenesis, creating a microenvironment conducive to cancer development. While...
by Combat Cancer | Jan 25, 2025 | News
Bladder cancer continues to be a pressing medical challenge, with different forms requiring different treatment approaches. While at Combat we primarily focus on non-muscle-invasive bladder cancer (NMIBC), recent advancements in diagnosing and treating the more...
by Combat Cancer | Jan 18, 2025 | News
Pancreatic cancer remains the world’s third deadliest form of cancer, behind lung and colorectal cancer. What makes pancreatic cancer so dangerous is largely due to its extremely aggressive nature and difficulties in early diagnosis. Among its various types,...
by Combat Cancer | Jan 10, 2025 | News
Non-Muscle-Invasive Bladder Cancer (NMIBC) is one of the most common forms of cancer worldwide, with around 2.5 times more men being affected than women. Age is another risk factor, with 56% of new cases being diagnosed in those aged 75 and over. However, treatments...
Recent Comments